mhurhangee/ep-ind-claims huggingface dataset:
An arrangement that makes possible an unaffected material analysis for the detection and analysis of at least one material deviation in a material, comprising a tactile sensor adapted to be placed in contact with the material and adapted to detect at least one region with a difference in hardness in the material, an arrangement (7, 8, 9) configured so that when a region with a different hardness is detected by the tactile sensor, it emits chromatographic light to illuminate the detected region with this light in order to obtain reflected light in the form of a light spectrum, and an arrangement configured to analyse the obtained light spectrum and to give information about the material in the region, its physical and chemical molecular structure.
A waveguide for guiding an electro-magnetic wave, said waveguide comprising: a first waveguide part; and a second waveguide part formed as a slab waveguide part; wherein the first waveguide part and the second waveguide part are configured to extend in a first plane and a second plane, respectively, the first and the second plane being parallel, wherein at least the first waveguide part is patterned in the first plane for defining a direction of propagation of the electro-magnetic wave in the first and the second planes through the waveguide; wherein the first or second waveguide part is arranged directly on a substrate; wherein the first waveguide part has a first width in a first direction perpendicular to the direction of propagation of the electro-magnetic wave and the second waveguide part has a second width in the first direction, wherein the second width is larger than the first width; and wherein the first and the second waveguide parts are spaced apart by a gap in a second direction perpendicular to the first and second planes, wherein the gap has a size which is sufficiently small such that the first and second waveguide parts (102, 104) unitely form a single waveguide for guiding the electro-magnetic wave whereby the guided electro-magnetic wave is jointly propagated by the first and second waveguide parts, characterized in that at least along a portion of the first and the second waveguide parts in the direction of propagation of the electro-magnetic wave, the gap defines a space, which is filled by a gas or a liquid. a first waveguide part; and a second waveguide part formed as a slab waveguide part; wherein the first waveguide part and the second waveguide part are configured to extend in a first plane and a second plane, respectively, the first and the second plane being parallel, wherein at least the first waveguide part is patterned in the first plane for defining a direction of propagation of the electro-magnetic wave in the first and the second planes through the waveguide; wherein the first or second waveguide part is arranged directly on a substrate; wherein the first waveguide part has a first width in a first direction perpendicular to the direction of propagation of the electro-magnetic wave and the second waveguide part has a second width in the first direction, wherein the second width is larger than the first width; and wherein the first and the second waveguide parts are spaced apart by a gap in a second direction perpendicular to the first and second planes, wherein the gap has a size which is sufficiently small such that the first and second waveguide parts (102, 104) unitely form a single waveguide for guiding the electro-magnetic wave whereby the guided electro-magnetic wave is jointly propagated by the first and second waveguide parts, characterized in that at least along a portion of the first and the second waveguide parts in the direction of propagation of the electro-magnetic wave, the gap defines a space, which is filled by a gas or a liquid.
Motor vehicle which comprises a bodywork shell which comprises at each of the lateral flanks a central pillar structure which delimits with an upper cross-member and a lower cross-member two door openings (5, 6), said central pillar structure comprising reinforcement means which comprise a first and a second reinforcement portion (8, 9) which are connected to each other and which are arranged along a vertical axis of the motor vehicle, said second reinforcement portion being arranged close to the lower cross-member, the motor vehicle being such that it comprises an additional reinforcement portion which is fixed to the inner surface of the second reinforcement portion close to a lower end of the first reinforcement portion, the motor vehicle being characterized in that the additional reinforcement portion is in the extension of the lower end of the first reinforcement portion and comprises at a lower end a rounded cut-out which surrounds an oblong central hole which is formed in the second reinforcement portion, the additional reinforcement portion being capable of guiding the deformation by means of flexion of the central pillar structure in the event of a lateral impact with an outer element at one of the lateral flanks.
A lubricating oil composition comprising a major amount of a base oil of lubricating viscosity and from 0.1 to 2 wt% based on the total weight of the composition of at least one lubricant antioxidant, the base oil consisting essentially of a Group III base oil prepared from synthesis gas by using a Fischer-Tropsch synthesis process, and a polyalphaolefin Group IV base oil wherein the weight ratio of the Group III to Group IV base oils is from 60:40 to 40:60, the lubricating composition exhibits an oxidation stability determined by a measure of high temperature deposits measured by the TEOST Test MH T-4 (ASTM D7097) that is less than half the mathematical sum of the oxidative stability determined for each of the unblended Group III and Group IV base oils containing the same antioxidant in the same amount as in the blend.
A method to determine in-vitro ASA (acetylsalicylic acid) resistance in subjects, based on determining the levels of MRP4 (Multidrug Resistance Protein 4) in platelets, such method comprising the following steps: (i) purify a sample of a biological fluid to obtain a platelet sample; (ii) either (a) put it into contact with an anti MRP4 mono- or poly-clonal antibody for a time sufficient for the formation of a complex between antigen MRP4 and said antibody, and detect and measure such complex by Western Blot; or (b) measure platelet MRP4-mRNA concentration by Southern Blot or Real Time PCR; said subjects being ASA resistant if presenting a higher platelet expression of MRP4 compared to healthy controls. (i) purify a sample of a biological fluid to obtain a platelet sample; (ii) either (a) put it into contact with an anti MRP4 mono- or poly-clonal antibody for a time sufficient for the formation of a complex between antigen MRP4 and said antibody, and detect and measure such complex by Western Blot; or (b) measure platelet MRP4-mRNA concentration by Southern Blot or Real Time PCR; (a) put it into contact with an anti MRP4 mono- or poly-clonal antibody for a time sufficient for the formation of a complex between antigen MRP4 and said antibody, and detect and measure such complex by Western Blot; or (b) measure platelet MRP4-mRNA concentration by Southern Blot or Real Time PCR;
A battery comprising: a case; a first unit cell including a first cathode; the first cathode including a lithium cobalt oxide, a first separator, a first anode, the first anode including graphite; and a plurality of second unit cells; each including a second cathode, the second cathode including a lithium phosphate having an olivine structure and containing at least one of cobalt, manganese, and iron, a second separator, and a second anode, the second anode including a lithium titanium oxide, wherein the first unit cell is interposed between the plurality of second unit cells within the case. a case; a first unit cell including a first cathode; the first cathode including a lithium cobalt oxide, a first separator, a first anode, the first anode including graphite; and a plurality of second unit cells; each including a second cathode, the second cathode including a lithium phosphate having an olivine structure and containing at least one of cobalt, manganese, and iron, a second separator, and a second anode, the second anode including a lithium titanium oxide, a second cathode, the second cathode including a lithium phosphate having an olivine structure and containing at least one of cobalt, manganese, and iron, a second separator, and a second anode, the second anode including a lithium titanium oxide,
Organic electroluminescent device, comprising cathode, anode and emitting layer, which comprises at least one luminescent organic compound which is an aromatic compound which has both donor and also acceptor substituents, where the donor substituents are selected from the group consisting of diaryl- or diheteroarylamino groups, carbazole groups and carbazole derivatives, which may in each case also be substituted, and where the acceptor substituents are selected from the group consisting of cyano groups and electron-deficient heteroaryl groups, which may also be substituted, and which has a separation between the lowest triplet state T 1 and the first excited singlet state S 1 of ≤ 0.15 eV (TADF compound), characterised in that the electroluminescent device comprises one or more electron-transport layers, each of which comprises at least one compound having an LUMO ≤ -2.55 eV, on the cathode side of the emitting layer.
A wireless communications method, performed by a terminal device, the wireless communications method comprising: receiving indication information on a first serving cell before on-duration period of a first discontinuous reception, DRX, cycle, wherein the indication information comprises a bitmap including bits wherein each bit indicates not to monitor a PDCCH corresponding to at least one second serving cell or to monitor a PDCCH corresponding to at least one second serving cell; and performing first processing in the on-duration period of the first DRX cycle if the indication information indicates not to monitor a physical downlink control channel PDCCH, wherein the first processing comprises at least one of the following: not monitoring a PDCCH on at least one second serving cell or not monitoring a PDCCH for the at least one second serving cell; or performing second processing in the on-duration period of the first DRX cycle if the indication information indicates to monitor a PDCCH, wherein the second processing comprises at least one of the following: monitoring a PDCCH on the at least one second serving cell or monitoring a PDCCH for the at least one second serving cell. receiving indication information on a first serving cell before on-duration period of a first discontinuous reception, DRX, cycle, wherein the indication information comprises a bitmap including bits wherein each bit indicates not to monitor a PDCCH corresponding to at least one second serving cell or to monitor a PDCCH corresponding to at least one second serving cell; and performing first processing in the on-duration period of the first DRX cycle if the indication information indicates not to monitor a physical downlink control channel PDCCH, wherein the first processing comprises at least one of the following: not monitoring a PDCCH on at least one second serving cell or not monitoring a PDCCH for the at least one second serving cell; or performing second processing in the on-duration period of the first DRX cycle if the indication information indicates to monitor a PDCCH, wherein the second processing comprises at least one of the following: monitoring a PDCCH on the at least one second serving cell or monitoring a PDCCH for the at least one second serving cell.
A peptide comprising an epitope immunoreactive with an anti-idiotypic antibody directed against an anti-p53 antibody, wherein the anti-p53 antibody is immunoreactive with at least a part of the regulatory domain of the C-terminus of p53, and wherein the peptide exhibits at least one activity selected from anti-apoptotic activity and anti-inflammatory activity, wherein the peptide has an amino acid sequence as set forth in SEQ ID NO: 1 for use in the treatment of amyotrophic lateral sclerosis.
Drying appliance, in particular washer-dryer or tumble dryer, having - at least one process air system, which comprises at least one closed process air circuit, at least one process air fan integrated in the process air circuit as well as at least one component (6, 7) arranged within the process air circuit and connected upstream of the process air fan on the suction side, in particular a heat exchanger, - at least one rinsing system for cleaning the component (6, 7) as part of at least one rinsing procedure, and - at least one appliance electronics system for controlling and/or regulating the process air fan and the rinsing system, which is configured to activate the process air fan at least temporarily during the rinsing procedure, wherein the process air fan is arranged in a region of a bend in the process air circuit and is embodied as a radial fan, characterised in that a process air duct of the process air circuit connected downstream of the process air fan on the pressure side and running at least partially radially with respect to a drive axis of the process air fan is axially subdivided at least in a subsection with respect to the drive axis into at least two duct sections (12, 13) separate from one another by way of at least one dividing wall. - at least one process air system, which comprises at least one closed process air circuit, at least one process air fan integrated in the process air circuit as well as at least one component (6, 7) arranged within the process air circuit and connected upstream of the process air fan on the suction side, in particular a heat exchanger, - at least one rinsing system for cleaning the component (6, 7) as part of at least one rinsing procedure, and - at least one appliance electronics system for controlling and/or regulating the process air fan and the rinsing system, which is configured to activate the process air fan at least temporarily during the rinsing procedure, wherein the process air fan is arranged in a region of a bend in the process air circuit and is embodied as a radial fan,
A method of making an oil-in-water microemulsion containing a polysiloxane, and an inert fluid selected from an inert siloxane fluid and an inert organic fluid, where the average emulsion particle size is between 1 and 140 nanometers (measured with a Nanotrac particle sizer in volume mode), comprising the steps of: a) preparing an oil phase comprising a polysiloxane containing mixture by the polymerisation of silane or siloxane containing monomers and/or oligomers in the presence of an inert fluid, a suitable catalyst and optionally an end-blocking agent; and b) where required quenching the polymerisation process; wherein the inert fluid is retained within the resulting polysiloxane containing mixture in an amount of from 5% to 70% w/w; c) if required, mixing one or more surfactants into the oil phase; d) adding water to the oil phase, followed by applying agitation or shear to the mixture to arrive at an oil-in-water microemulsion; e) optionally diluting the oil-in-water microemulsion by adding more water, and wherein the inert fluid is not removed prior to emulsification and is present in the microemulsion, and is selected from an organopolysiloxane extender and/or plasticiser, an organic extender and/or plasticiser, and a cyclic siloxane comprising between 3 and 20 silicon atoms. a) preparing an oil phase comprising a polysiloxane containing mixture by the polymerisation of silane or siloxane containing monomers and/or oligomers in the presence of an inert fluid, a suitable catalyst and optionally an end-blocking agent; and b) where required quenching the polymerisation process; wherein the inert fluid is retained within the resulting polysiloxane containing mixture in an amount of from 5% to 70% w/w; c) if required, mixing one or more surfactants into the oil phase; d) adding water to the oil phase, followed by applying agitation or shear to the mixture to arrive at an oil-in-water microemulsion; e) optionally diluting the oil-in-water microemulsion by adding more water, and
A cosmetic composition containing between 0.2 and 90 wt% of a mixture able to form an elastic film consisting of: - at least one starch with gelling or thickening action, likely to produce in water or in an aqueous phase, viscous colloidal solutions, suspensions or gels, and selected from starch hydrolyzates, - at least one polyol and - at least one polymer selected from polyvinyl alcohols and vinylpyrrolidone polymers and copolymers latex, in which mixture, the starch with gelling or thickening action represents between 10 and 20 wt% dry matter, the polymer represents from 35 to 45 wt% dry matter, and the polyol represents between 35 and 45 wt% dry matter, relative to the weight of the mixture, the sum of these three percentages being equal to 100. - at least one starch with gelling or thickening action, likely to produce in water or in an aqueous phase, viscous colloidal solutions, suspensions or gels, and selected from starch hydrolyzates, - at least one polyol and - at least one polymer selected from polyvinyl alcohols and vinylpyrrolidone polymers and copolymers latex, in which mixture, the starch with gelling or thickening action represents between 10 and 20 wt% dry matter, the polymer represents from 35 to 45 wt% dry matter, and the polyol represents between 35 and 45 wt% dry matter, relative to the weight of the mixture, the sum of these three percentages being equal to 100.
A computer-implemented method, comprising: calculating a center-of-mass of a volume of an organ of a patient in a computerized anatomical map of the volume; calculating paths (51a, 51b) from the center-of-mass to multiple locations on the surface of the volume; finding on the anatomical map a location on a surface of the volume that is farthest from the center-of-mass by finding a longest path among the multiple paths; identifying the location as belonging to a candidate anatomical opening of the organ; finding on the anatomical map a next-farthest location on a surface of the volume, which is farthest from the center-of-mass after excluding the identified candidate opening, and is farthest from the identified candidate opening among the multiple locations; identifying the next-farthest location as belonging to another candidate opening, finding on the anatomical map further next-farthest locations (50c, 50d, 50e, 50f) on the surface of the volume, which are farthest from the center-of-mass after excluding the identified candidate openings, and farthest from the identified candidate openings among the multiple locations; and identifying the next-farthest locations as belonging to further candidate openings (49c, 49d, 49e, 49f). calculating a center-of-mass of a volume of an organ of a patient in a computerized anatomical map of the volume; calculating paths (51a, 51b) from the center-of-mass to multiple locations on the surface of the volume; finding on the anatomical map a location on a surface of the volume that is farthest from the center-of-mass by finding a longest path among the multiple paths; identifying the location as belonging to a candidate anatomical opening of the organ; finding on the anatomical map a next-farthest location on a surface of the volume, which is farthest from the center-of-mass after excluding the identified candidate opening, and is farthest from the identified candidate opening among the multiple locations; identifying the next-farthest location as belonging to another candidate opening, finding on the anatomical map further next-farthest locations (50c, 50d, 50e, 50f) on the surface of the volume, which are farthest from the center-of-mass after excluding the identified candidate openings, and farthest from the identified candidate openings among the multiple locations; and identifying the next-farthest locations as belonging to further candidate openings (49c, 49d, 49e, 49f).
A computer implemented method for medical image fusion by a medical imaging system, the method comprising: dividing a first medical image into patches; characterized by for each patch, extracting an input feature vector of intensities of the first medical image for the patch, a first displacement vector of the patch based on similarity with a second medical image, intensities of the first medical image for neighboring ones of the patches, and second displacement vectors of the neighboring patches based on similarity with the second medical image; generating a deep-learnt feature vector from application of the input feature vector to a deep machine-learnt classifier; determining non-rigid deformation of the first medical image relative to the second medical image from the deep-learnt feature vector; and fusing the first medical image with the second medical image based on the non-rigid deformation. dividing a first medical image into patches; characterized by for each patch, extracting an input feature vector of intensities of the first medical image for the patch, a first displacement vector of the patch based on similarity with a second medical image, intensities of the first medical image for neighboring ones of the patches, and second displacement vectors of the neighboring patches based on similarity with the second medical image; generating a deep-learnt feature vector from application of the input feature vector to a deep machine-learnt classifier; determining non-rigid deformation of the first medical image relative to the second medical image from the deep-learnt feature vector; and fusing the first medical image with the second medical image based on the non-rigid deformation.
A recombinant protein, comprising: (a) a mutant of alpha subunit of a flavin-adenine dinucleotide glucose dehydrogenase (FAD-GDH); and (b) a magnetotactic bacterius minimal c-type cytochrome peptide being a cytochrome domain MCR-2 from a MamP protein, wherein said mutant of FAD-GDH is encoded by a DNA sequence being at least 70% identical to SEQ ID NO: 1, and wherein said recombinant protein is characterized by having both peroxidase activity and oxidative activity.